|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| C07B 59/00 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Number of the document | 2536727 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11704225.9 |
| Date of filing the European patent application | 2011-02-17 | |
| (97) | Date of publication of the European application | 2012-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/052365 |
| Date | 2011-02-17 |
| (87) | Number | WO 2011/101417 |
| Date | 2011-08-25 |
| (30) | Number | Date | Country code |
| 306248 P | 2010-02-19 | US |
| (72) |
BRAIN, Christopher Thomas, US
PEREZ, Lawrence Blas, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 |
| DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 |